Challenge trials have long history, going back to development of smallpox vaccine in 1796
No COVID-19 Vaccines Allowed in California Without State Approval
California governor says vaccinations ‘will move at the speed of trust’
Inactivated SARS-CoV-2 Vaccine Well Tolerated in Phase 1/2 Trial
Neutralizing antibody geometric mean titers higher in vaccine group at day 42 in phase 1 trial
COVID-19-Linked Deaths Mainly in Seniors in May to August 2020
Percentage of decedents who were Hispanic increased from 16.3 to 26.4 percent in May to August
No Pfizer COVID-19 Vaccine Expected Before Election
Company has reversed its previous claims that it would apply for the approval in October
Emergency Sick Leave Helped to Flatten the U.S. COVID-19 Curve
Compared with before sick leave, newly gained sick leave led to 400 fewer confirmed cases per day
Neurologic Complications Seen in Hospitalized COVID-19 Patients
Neurologic disorders tied to increased risk for in-hospital mortality
No Evidence Found of Vertical Transmission of SARS-CoV-2
Newborns of mothers with severe/critical COVID-19 born early, at risk for needing phototherapy
Time to Results Faster With Point-of-Care COVID-19 Testing
Time to results significantly shorter with QIAstat-Dx Respiratory SARS-CoV-2 Panel than with PCR
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir